Merck & Company, Inc. (MRK)

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded partnership with Citeline. Citeline is a leading provider of data, analytics, and insights to companies in the life sciences and pharmaceutical industries. As part of the […]

Tempus AI Inc (NASDAQ:TEM) is among the best medical AI stocks to buy now. Tempus has partnered with SoftBank, Gilead, and Merck on AI-driven drug development programs. Analysts are growing more confident in Tempus amid its expanding partnerships. On April 13, TD Cowen upgraded Tempus AI Inc (NASDAQ:TEM) to a Buy rating from Hold, though […]

Does EU Approval Of ENFLONSIA Reshape The Bull Case For Merck’s Pipeline Story (MRK)?

Earlier this week, the European Commission approved Merck’s ENFLONSIA (clesrovimab), a long-acting monoclonal antibody to prevent RSV lower respiratory tract disease in newborns and infants during their first RSV season across the EU, Iceland, Liechtenstein and Norway. This decision adds another globally approved product backed by late-stage CLEVER and SMART trial data to Merck’s growing portfolio of infant and pediatric preventive therapies. We’ll now examine how adding an EU-wide RSV...

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks climbed late Friday afternoon, with the NYSE Health Care Index rising 1.4% and th

Both are great stocks to buy in the current environment, but which one is the better bet?